| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/30/2009 | WO2009093026A1 Compounds having crth2 antagonist activity |
| 07/30/2009 | WO2009092606A2 Composition |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009047505A3 Dexanabinol with inhibitors of braf or mek for the treatment of melanoma |
| 07/30/2009 | WO2008103613A3 Hydroxylamine compounds and methods of their use |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192202 4-(2-Cyano-cyclohexyloxy)-2-trifluoromethyl-benzonitrlle; selective androgen receptor modulators; decrease excess sebum secretions; stimulants of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer |
| 07/30/2009 | US20090192126 Oral Composition Comprising a Polyunsaturated Fatty Acid and Salicylic Acid for Obtaining an Antiinflammatory Effect in Skin |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192086 Identification of a novel bhd gene |
| 07/30/2009 | US20090192079 Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191288 Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases |
| 07/30/2009 | US20090191214 Anti-human il-21 monoclonal antibodies |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191163 Primed tissue for tissue engineering and methods of priming tissue |
| 07/30/2009 | US20090191156 Gm-csf cosmeceutical compositions and methods of use thereof |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | CA2713071A1 Composition |
| 07/30/2009 | CA2712748A1 13,13-dimethyl-des-c,d analogs of 1.alpha.,25-dihydroxy-19-nor-vitamin d3 compounds and topical composition dosage forms and methods of treating skin conditions thereof |
| 07/30/2009 | CA2712512A1 Use of serine protease inhibitors in the treatment of skin diseases |
| 07/30/2009 | CA2711887A1 Dihydro-1h-pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| 07/29/2009 | EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 07/29/2009 | EP2082744A1 Pharmaceutical composition comprising nitric acid and a zinc salt and medial device for treating skin lesions |
| 07/29/2009 | EP2082736A1 Pharmaceutical composition for local use |
| 07/29/2009 | EP2081578A1 Combination of a glucocorticoid and a beta-cyclodextrin conjugated vitamin a derivate complex |
| 07/29/2009 | EP1987817B1 Pharmaceutical composition of microspheres for preventing diabetic foot amputation |
| 07/29/2009 | EP1694370A4 Wound care products containing keratin |
| 07/29/2009 | EP1455772B1 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519552C Pyrazole compounds |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100518748C Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract |
| 07/29/2009 | CN100518747C Matrix metalloprotease inhibitor |
| 07/29/2009 | CN100518745C Organic extract for Japonicum Thunb and application thereof |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566778 Central nervous system disorders; psychological disorders |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566734 Imidazolyl derivatives |
| 07/28/2009 | US7566720 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 07/28/2009 | US7566698 Extracted from plants such as Ningxia Lycium barbarum L. and/or Lycium chinense Mill; glucosyltransferases, cellulases; provitamin C with improved stability and bioavailability; ultraviolet damage protector; antiwrinkling; whitening |
| 07/28/2009 | US7566694 Anti-pathogen treatments |
| 07/28/2009 | US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 07/28/2009 | US7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/28/2009 | CA2617465A1 Triple spin, double pool and revolumization process for concentrating platelets, and derivative platelet concentrate |
| 07/28/2009 | CA2408541C Treating eczema and/or psoriasis |
| 07/28/2009 | CA2366996C Ascorbic acid composition and method for treatment of aging or damaged skin |
| 07/23/2009 | WO2009091889A1 Treatment of skin disorders with egfr inhibitors |
| 07/23/2009 | WO2009091764A2 Beta-lactams for the treatment of glaucoma, ocular hypertension, baldness and hair loss |
| 07/23/2009 | WO2009090950A1 Chitosan-containing compositions and process for production thereof |
| 07/23/2009 | WO2009090394A2 Composition containing capsicum for treating a skin disorder |
| 07/23/2009 | WO2009090345A2 Use of essential oil for preparing a cosmetic or pharmaceutical composition |
| 07/23/2009 | WO2009089880A1 Preparation containing chromane-2-one derivatives |
| 07/23/2009 | WO2009026158A3 Inflammation-regulating compositions and methods |
| 07/23/2009 | WO2008139182A3 Skin care composition |
| 07/23/2009 | WO2008084171A9 Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component |
| 07/23/2009 | WO2008071546A3 Use of styphnolobium |
| 07/23/2009 | WO2008056388A8 Drug based on ozonized terpenes or terpene-derivatives, processes for producing it and uses thereof |
| 07/23/2009 | WO2007143146A3 Method of treating inflammatory diseases using tyroskine kinase inhibitors |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186853 Compositions comprising n-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof |
| 07/23/2009 | US20090186851 Hemostatic material |
| 07/23/2009 | US20090186826 Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides |
| 07/23/2009 | US20090186821 Use of aspartic proteases in cosmetics and therapeutics |
| 07/23/2009 | US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 07/23/2009 | US20090186111 Novel Bacteria and Pharmaceutically Active Products Obtained Therefrom |
| 07/23/2009 | US20090186104 Herbal compositions for the treatment of mucosal lesions |
| 07/23/2009 | US20090186100 Medicament for anti-aging skin care and wound healing and use thereof |
| 07/23/2009 | US20090186095 Human hair root stimulator using emu oil to deliver specific therapeutic grade essential oils to the hair follicle |
| 07/23/2009 | US20090186071 Clay-based hemostatic agents and devices for the delivery thereof |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186021 Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents |
| 07/23/2009 | US20090186013 Inorganic materials for hemostatic modulation and therapeutic wound healing |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/23/2009 | US20090186008 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2009 | US20090185990 Bioactive compositions from theacea plants and processes for their production and use |
| 07/23/2009 | CA2712527A1 Chitosan gel for dermatological use, production method and use of same |
| 07/23/2009 | CA2712389A1 Composition for treating a skin disorder |
| 07/23/2009 | CA2712264A1 Therapeutic beta-lactams |
| 07/22/2009 | EP2081028A1 Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness |
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080504A2 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 07/22/2009 | EP2079676A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 07/22/2009 | EP2079473A1 Dermatological composition containing avermictin nanocapsules, method for preparing the same and uses thereof |
| 07/22/2009 | EP2079471A2 Food extracts containing n-methylnicotinamide for treatment of lipoprotein abnormalities and skin diseases and disorders |
| 07/22/2009 | EP2079460A2 Cosmetic oral and/or parenteral use of glucosamine optionally in combination with at least one polyphenol compound, and corresponding composition |
| 07/22/2009 | EP2079459A2 Method of treating asthma, allergic rhinitis, and skin disorders |
| 07/22/2009 | EP2079440A2 Two-compartment skincare products comprising ivermectin, and uses thereof |
| 07/22/2009 | EP1998784B1 Medicaments and methods comprising a compound that promotes oestrogenic activity for wound healing |